# Topical Chemoprevention of Skin Cancer Biomarkers

> **NCT02636569** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 24 (actual)

## Conditions studied

- Non-melanoma Skin Cancer

## Interventions

- **DRUG:** topical diclofenac daily
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02636569
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-25
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636569, "Topical Chemoprevention of Skin Cancer Biomarkers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02636569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*